Behaviour of Cell Lines in a Selection Strategy

Similar documents
Improving GS-CHO Cell Line Selection: Reducing Time to Clinic

ESTABLISHMENT OF CELL LINES FOR MANUFACTURING RECOMBINANT ANTIBODIES. Dr Andrew Racher

The Importance of Developing a High Yield of Product

Selection of Cell Lines for Manufacturing Therapeutic Antibodies by Flow Cytometric Cell Sorting. Andrew Racher Lonza Biologics

Accelerating Antibody Process Development: Exploring the Synergies Between Engineered Host Cells and Process Development

How To Develop A Cell Line

Potelligent CHOK1SV. European Antibody Congress 30 Nov - 02 Dec, Geneva, Switzerland. Alison Porter, 2009 Lonza Biologics plc, Slough, UK

Important Topics in the Expression of Recombinant Antibodies from CHO Cells

High yield antibody production in a disposable WAVE Bioreactor

BioProcessing J O U R N A L. Trends and Developments in BioProcess Technology. Volume 9 Issue 1 ISSN

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE Q5B

A customizable ADCC assay service for antibodies & fusion proteins.

Accelerating drug development to FTIH: Potential of new expression technologies

European Medicines Agency

Luca Romagnoli, Ph.D. Business Development Manager

Cell Culture Technology for Pharmaceutical and Cellular Therapies

THE PREDICTIVE MODELLING PROCESS

OriGene Technologies, Inc. MicroRNA analysis: Detection, Perturbation, and Target Validation

EMABling Antibody Production Platform

Animal Cell Culture. Third Edition. A Practical Approach OXJORD VNIVVRSITY 1'RVSS

LFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals

Investigating the genetic basis for intelligence

LFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals

Learning Predictive Models of Gene Dynamics. Nick Jones, Sumeet Agarwal

restriction enzymes 350 Home R. Ward: Spring 2001

Exciting Trends in Bioprocessing

Valentina Gualato, Ph.D. Process Development Scientist

General Properties Protein Nature of Enzymes Folded Shape of Enzymes H-bonds complementary

Application Note USD3013. Monoclonal Antibody Production in Suspension CHO Culture Using Single-Use PadReactor Mini Bioreactor

BACTERIAL ENUMERATION

Testing Metrics. Introduction

Answer Key Problem Set 5

Molecular Biology Techniques: A Classroom Laboratory Manual THIRD EDITION

Triskel: a strategic consulting firm for biopharmaceutical companies

Observing and describing the behavior of a subject without influencing it in any way.

Amaxa Mouse T Cell Nucleofector Kit

Dr.ssa Maria Luisa Nolli CEO

Descriptive Statistics

INTERFERin in vitro sirna/mirna transfection reagent PROTOCOL. 1 Standard sirna transfection of adherent cells... 2

Process Performance Qualification. Demonstrating a High Degree of Assurance in Stage 2 of the Process Validation Lifecycle

MOL.911 HNL Expression

Integrated Protein Services

A role of microrna in the regulation of telomerase? Yuan Ming Yeh, Pei Rong Huang, and Tzu Chien V. Wang

Why Taking This Course? Course Introduction, Descriptive Statistics and Data Visualization. Learning Goals. GENOME 560, Spring 2012

GRS Plasmid Purification Kit Transfection Grade GK (2 MaxiPreps)

Secretion Assay Cell Screening Service Gel Microdrop

How to Measure a Loyalty Programme s Return on Investment. Managing information and transactions securely

Chemistry 2351: Inorganic Chemistry I Laboratory Manual

DETECTION OF BACTERIAL MOTILITY. To demonstrate bacterial motility by microscopic and macroscopic techniques.

STOP. Before using this product, please read the Limited Use License statement below:

HCS Exercise 1 Dr. Jones Spring Recombinant DNA (Molecular Cloning) exercise:

SURVEY DESIGN: GETTING THE RESULTS YOU NEED

Quantitative Software Management

Guideline for Generation of Stable Cell Lines Technical Reference Guide

Towards energy-based dynamic optimization of monoclonal antibody producing GS-NS0 Cultures

Integrated Protein Services

The use of FACS for the selection of cell lines with superior productivity characteristics

Validation and Calibration. Definitions and Terminology

Proto col. GoClone Repor ter Construc ts: Sample Protocol for Adherent Cells. Tech support: Luciferase Assay System

The course breaks down the Procurement Process into 5 Steps

Vaccine Manufacturing Facilities of the Future. Howard L. Levine, Ph.D. Vaccines Europe London, England December 1 2, 2010

Six Sigma Acronyms. 2-1 Do Not Reprint without permission of

Software Metrics. Lord Kelvin, a physicist. George Miller, a psychologist

Molecular Genetics: Challenges for Statistical Practice. J.K. Lindsey

Software Engineering. Introduction. Software Costs. Software is Expensive [Boehm] ... Columbus set sail for India. He ended up in the Bahamas...

Description: Molecular Biology Services and DNA Sequencing

QbD based Development and Characterization of a Cell Culture Process for Therapeutic Proteins

MTH 140 Statistics Videos

Specific Challenges in Large-Scale Manufacturing of Peptide as API s Presentation at TIDES Conference, Las Vegas, April 25 29, 2004

Hydroxynitrile lyase (Hnl)

TransIT Transfection Reagent

Environmental Monitoring

MGC premier Expression-Ready cdna clones TCH1103, TCM1104, TCR1105, TCB1106, TCH1203, TCM1204, TCR1205, TCB1206, TCH1303, TCM1304, TCR1305

Statistical tests for SPSS

Facility construction and start up for commercial scale manufacturing of monoclonal antibodies - A case study

Simplifying Unconstrained Fixed Income Investing

SPE Copyright 1999, Society of Petroleum Engineers Inc.

Cell Phone Radiation Effects on Cancer. Tyler Barkich Central Catholic High School Grade 11

Financial Risk Management Exam Sample Questions

High deleterious genomic mutation rate in stationary phase of Escherichia coli

American Statistical Association

Introduction to Hypothesis Testing. Hypothesis Testing. Step 1: State the Hypotheses

Use of the ambr 250 in combination with high-throughput design and analysis tools for rapid, scalable USP development

PRODUCT INFORMATION...

Transfection-Transfer of non-viral genetic material into eukaryotic cells. Infection/ Transduction- Transfer of viral genetic material into cells.

CALCULATIONS & STATISTICS

4.1 3T12 and 312 are immortalized cell lines with transforming potential:

Easy Collection and Extraction of BioSamples Ahlstrom GenCollect Ahlstrom GenCollect Color

Statistics I for QBIC. Contents and Objectives. Chapters 1 7. Revised: August 2013

Interpretation of Regulatory Guidance on Dodd Frank Investment Grade Due Diligence

Overview of Upstream and Downstream Processing of Biopharmaceuticals

3 Chapter Three: Material and methods (clone creation, upstream and downstream process)

The Public Policy Process W E E K 1 2 : T H E S C I E N C E O F T H E P O L I C Y P R O C E S S

ISyE 2028 Basic Statistical Methods - Fall 2015 Bonus Project: Big Data Analytics Final Report: Time spent on social media

Program Visualization for Programming Education Case of Jeliot 3

business statistics using Excel OXFORD UNIVERSITY PRESS Glyn Davis & Branko Pecar

The Big Data Paradigm Shift. Insight Through Automation

A Batch Computing Service for the Spot Market. Supreeth Subramanya, Tian Guo, Prateek Sharma, David Irwin, Prashant Shenoy

Introduction to Bioprocessing

MEF Starter Nucleofector Kit

Transcription:

Cell Line Development and Engineering 27 Behaviour of Cell Lines in a Selection Strategy Alison Porter, Lonza Biologics plc, Slough, GB, 6 March 27

Scope of Talk Cell line construction Issues and Requirements Current cell line construction strategy Challenging the current cell line selection strategy slide 2

Cell Line Construction Issues and Requirements

Cell Line Construction Issues and Requirements Issue: Transfection results in heterogeneous population Measurements made early in construction of a cell line may not reflect how it behaves in the final production process Requirement: Selection of cell lines with appropriate specific production rates (Q P ) and growth characteristics slide 4

Cell Line Construction Issues and Requirements A possible strategy Take large numbers (possibly thousands) of cell lines through to the final production process Scientifically sound Lengthy and resource intensive Developing other strategies Designed with reference to the final production process Requires prediction of manufacturing behaviour of cell lines at very early stage Economic Compatible with resources slide 5

Cell Line Construction Objectives Objective of any cell line selection strategy is to isolate cell line(s) that: Are high volumetric producers Show acceptable growth in final inoculum processes Show desired product quality Including bioactivity slide 6

Current Cell Line Construction Strategy

Current Cell Line Construction Strategy Vectors designed to promote expression of the gene(s) of interest (GOIs) Strong promoter (hcmv) drives expression of the GOIs Weak promoter (SV4) on GS gene is coupled with selection in high (stringent) levels of MSX selects for integration at transcriptionally active loci GOIs and GS gene are on the same plasmid and tightly linked Integration of GS gene into transcriptionally active loci results in co-integration of GOIs into same loci slide 8

Current GS-CHO Cell Line Construction Method Transfect CHOK1SV host cells with vector 96-well plates, single colonies per well Static culture - CDACF medium 2 3 cell lines Semi-quantitative productivity assessment 1-15 cell lines Quantitative productivity assessment 3 6 cell lines Suspension (shake-flask) culture - CDACF medium Select cell lines for stability assessment 5-1 cell lines Adapt to suspension culture 3 6 cell lines Preliminary quantitative assessment Select cell lines to clone Fed-batch assessment of growth, productivity and product quality slide 9

Fed-Batch Shake-Flask Screen of GS-CHO Cell Lines 4 2.5 Product Concentration (mg/l) 35 3 25 2 15 1 5 Q P (pg/cell/hour) 2 1.5 1.5 35 Antibody 2 Antibody IVC (1 6 cells.h/ml) 3 25 2 15 1 5 Max X V (1 6 cells/ml) 18 16 14 12 1 8 6 4 2 Antibody Antibody slide 1

Batch and Fed-Batch Culture: Comparison of Ranking Positions Examples from two GS-CHO construction programmes 2 2 4 Rank Position 4 6 8 1 Rank Position 6 8 1 12 14 16 18 12 Preliminary Productivity Assessment Scale-down Model of the Final Production Process Individual cell lines respond differently to feed Change in rank position 2 Preliminary Productivity Assessment Scale-down Model of the Final Production Process slide 11

Fed-Batch Shake-Flask vs. Fed-Batch Bioreactor 3 Value in Bioreactor Relative to Shake-Flask 2.5 2 1.5 1.5 Product Concentration Parameter Relationship between productivity characteristics of the lead GS-CHO cell lines making ten different antibodies Individual cell lines respond differently to culture in bioreactors Q P slide 12

Current Cell Line Construction Strategy - Summary Individual cell lines respond differently to environment Feed Bioreactor Suggests requirement for more powerful strategies for selecting best cell lines A better model of the bioreactor likely to be a key requirement slide 13

Challenging The Current Cell Line Selection Strategy

Challenging The Current Cell Line Construction Strategy Objective: to increase the frequency of isolating the best 5% of cell lines With no change in resource requirement or elapsed time Potential issue High producing cell lines are isolated using the current cell line construction strategy Are these good cell lines rather than the best cell lines? Lowest producers discarded at each stage and response of cells to environment differs. Limitations with assessment of available data Initial work to fully understand what happens in current selection strategy may therefore help fulfil the objective slide 15

Challenging The Current Cell Line Construction Strategy Hypothesis: A screen stage fully predicts the behaviour of the cell lines in the subsequent screens Is any screen truly predictive? At each stage cell line(s) are discarded/selected which do/don t do well in a particular system How? Progression of 175 randomly selected cell lines from transfection through all selection stages prior to fermentation Assessment of a subset of these in bioreactors slide 16

Challenging The Current Cell Line Selection Strategy - Method Transfect CHOK1SV host cells with vector 96-well plates, single colonies per well 175 cell lines Semi-quantitative productivity assessment spot Static culture - CDACF medium 175 cell lines Quantitative productivity assessment 24-well plate 175 cell lines Suspension (shake-flask) culture - CDACF medium Adapt to suspension culture Bioreactor assessment 175 cell lines 175 cell lines Preliminary quantitative assessment batch Pseudo-random selection of 29 cell lines for bioreactors Fed-batch assessment slide 17

Challenging The Current Cell Line Selection Strategy Productivity Results Specific Activity Spot Product Concentration (mg/l) 35 3 25 2 15 1 5 24-well plate Product Concentration (mg/l) 9 8 7 6 5 4 3 2 1 Batch Cell Line Product Concentration (mg/l) 3 25 2 15 1 5 Fed-batch Cell Line Cell Line Cell Line slide 18

Challenging The Current Cell Line Selection Strategy Location of Selected Top 1 Current selection strategy used to identify top 1 cell lines from the 175 cell lines Spot : 175 12 cell lines 24-well plate : 12 6 cell line Batch : 6 1 cell lines These cell lines designated the selected top 1 Would progress to assessment in fed-batch screen Where are these ten cell lines at each screen stage? slide 19

Specific Activity Challenging The Current Cell Line Selection Strategy Location of Selected Top 1 Spot Product Concentration (mg/l) 35 3 25 2 15 1 5 24-well plate Product Concentration (mg/l) 9 8 7 6 5 4 3 2 1 Batch Cell Line Product Concentration (mg/l) 3 25 2 15 1 5 Fed-batch Cell Line Cell Line Cell Line slide 2

Challenging The Current Cell Line Selection Strategy Location of selected Top 1 Use of the selection strategy has not resulted in the selection of the top ten highest producers at the fed-batch stage Where are the real top ten cell lines at each stage? Location of the ten highest producers identified in the fed-batch screen What happens if screen stages are missed out? slide 21

Specific Activity Challenging The Current Cell Line Selection Strategy Location of the Real Top 1 Spot Product Concentration (mg/l) 35 3 25 2 15 1 5 24-well plate Product Concentration (mg/l) 9 8 7 6 5 4 3 2 1 Batch Cell Line Product Concentration (mg/l) 3 25 2 15 1 5 Fed-batch Cell Line Cell Line Cell Line slide 22

Challenging The Current Cell Line Selection Strategy Removal of Screen Stages Product Concentration (mg/l) 3 25 2 15 1 5 Selected top ten Product Concentration (mg/l) 3 25 2 15 1 5 Assessing spot data only Product Concentration (mg/l) 3 25 2 15 1 5 Cell Line Removing the 24-well plate screen Product Concentration (mg/l) 3 25 2 15 1 5 Cell Line Removing the batch screen Cell Line Cell Line slide 23

Challenging The Current Cell Line Selection Strategy Cell Line Locations Summary Use of the current selection strategy does result in the selection of highly productive cell lines Use of the current selection strategy does not result in the selection of all ten cell lines which are the highest producers in the fed-batch screen It is possible to discard cell lines which would be high producers Use of the spot screen alone is not sufficient to identify a high producing cell line May be possible to have just the 24-well plate or batch screen stage rather than both? Could then refocus resource on the fed-batch screen Further statistical analysis is in progress to investigate this slide 24

Challenging The Current Cell Line Selection Strategy Ranking Progress to examine whether ranking position of cell line changes between each screen Are the screens truly predictive? slide 25

Challenging The Current Cell Line Selection Strategy Ranking -2 High ranking Rank Position 2 4 6 8 1 12 14 16 18 2 'spot' '24-well plate' 'batch' 'fed-batch' Low ranking slide 26

Challenging The Current Cell Line Selection Strategy Ranking -2 High ranking Rank Position 2 4 6 8 1 12 14 16 18 2 'spot' '24-well plate' 'batch' 'fed-batch' Low ranking slide 27

Challenging The Current Cell Line Selection Strategy Ranking Ranking position of a cell line can change as it moves through the different screens Movement both up and down can be observed Those cell lines which are initially the lowest producers tend to remain as low producers throughout each screen Is the ranking position in one screen predictive of the ranking position in the next screen? slide 28

Challenging The Current Cell Line Selection Strategy Contingency Tables 4 4 Number of Cell Lines 3 2 1 1 2 3 Quartile in 'spot' 4 1 2 3 4 Quartile in '24- Well Plate' Number of Cell Lines 3 2 1 1 Quartile in '24-Well Plate' 2 3 4 1 2 3 4 Quartile in 'Batch' Initial statistical analysis suggests there is a relationship between variables Number of Cell Lines 4 3 2 1 1 2 3 Quartile in 'Batch' 4 1 2 3 4 Quartile in 'Fed- Batch' Propose that this relationship primarily due to those which are low producers tending to remain low producers through each screen slide 29

Challenging The Current Cell Line Selection Strategy Bioreactor Results A subset of the 175 cell lines were assessed in 1 L bioreactors 29 cell lines assessed How do results in shake-flasks compare to results in bioreactors for these cell lines? slide 3

Bioreactor: Product Concentration (mg/l) Bioreactor: IVC (1 6 cells/ml.h) Challenging The Current Cell Line Selection Strategy Bioreactor Results 35 3 25 2 15 1 5 7 6 5 4 3 2 1 5 1 15 2 25 3 35 Shake-flask: Product Concentration (mg/l) 1 2 3 4 5 6 7 Shake-Flask: IVC (1 6 cells/ml.h) Bioreactor: Q P (pch) 1.4 1.2 1..8.6.4.2...2.4.6.8 1. 1.2 1.4 Shake-Flask: Q P (pch) Positive correlation between shake-flask and bioreactor results for: Product concentration (r =.86, p =.5) Q P (r =.94, p =.5) IVC (r =.46, p =.5) slide 31

Challenging The Current Cell Line Selection Strategy Bioreactor Results Selected top ten highlighted: Bioreactor: Product Concentration (mg/l) 35 3 25 2 15 1 5 Changes in rank position observed 5 1 15 2 25 3 35 Shake-flask: Product Concentration (mg/l) A cell line which is highly productive in the final production process can be selected It may not be the highest producer slide 32

Challenging The Current Cell Line Selection Strategy Bioreactor Results There is positive correlation between results obtained in shake-flasks and bioreactors for productivity characteristics and for IVC Seen for a range of productivities Rank positions may change between shake-flasks and bioreactors Although prediction of the highest producer in the bioreactor did not occur, a high producing cell line was still identified slide 33

Challenging The Current Cell Line Selection Strategy Summary Variation in measured parameters observed at each assessment stage Ranking positions not consistent as cell lines progress through the different assessment stages Heterogeneous response of cell lines to environment Cell lines which would exhibit good characteristics in the final production process can be discarded during the selection strategy Fed-batch shake-flask screen not truly predictive of behaviour in bioreactor Reject the hypothesis that any screen fully predicts the behaviour in subsequent screens However, use of the current selection strategy still enables identification of highly productive cell lines slide 34

Challenging The Current Cell Line Selection Strategy Summary Initial statistical analysis does suggest a relationship between the screens Low producers tend to remain low producers slide 35

Challenging The Current Cell Line Selection Strategy Discussion Possible reasons for why each assessment stage is not truly predictive of the next: Loss of GOI A cell line which is high producing at one screen and then low producing at the rest Pseudo-random integration of the integrated genes throughout the genome Susceptibility of loci to epigenetic affects Affect of loci on mrna transport Affect of loci on functioning of other genes in adjacent areas slide 36

Challenging The Current Cell Line Selection Strategy The future As current selection strategy is not truly predictive of behaviour in final selection strategy, there is an opportunity to improve the selection strategy Statistical analysis to determine how many cell lines to screen at each stage to increase frequency of identification of best 5% cell lines Remove a screen stage and refocus resource onto one of the other screen stages? Screen more cell lines at the later stages? Develop more predictive early assessments? Although not necessarily the best cell lines, very good cell lines can be isolated in the current selection strategy slide 37

Acknowledgements Lonza Biologics plc, Slough, GB Andy Racher Juanita Porter Atul Mohindra Emma Allen Tracy Root Eric Le Guern Richard Aldcroft Cell Culture Process Development Group Analytical Development Group University of Manchester Alan Dickson Louise Barnes slide 38